Loading clinical trials...
Loading clinical trials...
The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complicat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
George Washington University
NCT07470151 · System Lupus Erythematosus(SLE), Scleroderma, and more
NCT06801119 · Systemic Lupus Erythematosus, Scleroderma, and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT06843239 · Systemic Sclerosis (SSc), Scleroderma
NCT07256418 · Scleroderma
Victoria K Shanmugam
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions